Cannabinomics

facebooktwittergoogle_plusredditpinterestmail

Order Your Autographed copy of Cannabinomics today!

Dr. Fichtner has generously donated several signed copies of  “Cannabinomics” – The Marijuana Policy Tipping Point,  to The Human Solution as a fundraiser for legal defense.

Because of his generosity The Human Solution is able to offer you a signed copy of this acclaimed book for only a $20.00 donation  for a limited time, while they last. Please show your support and order your copy today!!

Dr. Fichtner talks with The Human Solution about Cannabinomics


Christopher Glenn Fichtner, M.D.

A revolutionary new book that reframes the marijuana debate and offers a new paradigm for public conversation on key drug policy isssues of our time

“It is time to talk about American drug policy,” writes psychiatrist and former state mental health director Christopher Glenn Fichtner, M.D. But this new conversation requires a new vocabulary: “the demonization of American marijuana policy has been so extreme, and the conceptual distoritons of American marijuana is so profound, that the word `marijuana` itself is no longer servicable for the public.”

 

Praise for Cannabinomics

“…an incisive administrative and clinical analysis that dissects the failure of American drug policy and charts a bright future for medicinal cannabis.”

David Bearman, M.D. Founding board Member and VIce President, American Academy of Cannabinoid Medicine; Author of Demons, Discrimination and Dollars: A Brief History of the Origins of American Drug Policy (Prosperity Press, 2008)

“… a must read for anyone interested in cannabis policy reform. A highly experienced psychiatrist has put the facts, myths and opinions that swirl around the drug policy reform into one comprehensive book that allows the reader to see through the fog of the drug was rhetoric and partisan propaganda.”

David G. Ostrow, M.D., Ph.D, Senior Resaerch Associate, Ogburn-Stouffer Center for Organizational Reasearch, NORC at the University of Chicago; Founding Principle Investigator & Chair, Behavioral Working Group of the MultiCenter AIDS Cohort Study; Chair, Scientific Advisory Board, Americans for Safe Access